Renal Cancers Recruiting Phase 1 / 2 Trials for Guadecitabine (DB11918)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03308396Study of Durvalumab and Guadecitabine in Advanced Kidney CancerTreatment